Next, to investigate the impact of ERBB3 on Gem resistance in PDAC patients, we performed qRT-PCR assays in clinical tissue specimens from patients with unresectable cancers obtained by EUS-FNA before initiation of treatment. Here, ERBB3 is linked to cancer.